Logo image
Drug labeling in the practice of obstetric anesthesia
Journal article   Peer reviewed

Drug labeling in the practice of obstetric anesthesia

Brendan Carvalho and Cynthia A. Wong
American journal of obstetrics and gynecology, Vol.212(1), pp.24-27
01/01/2015
DOI: 10.1016/j.ajog.2014.04.040
PMID: 24799312

View Online

Abstract

This commentary outlines the current drug labeling practices that potentially compromise the clinical care of pregnant women and their children. We highlight the need for drug manufacturers and lawmakers to change the status quo and consider practices and regulations that will provide much-needed guidance to clinicians on the safe administration of drugs to certain populations such as pregnant and nursing women. Current practices have de facto contributed to a situation in which evidence is inadequate for individual physicians and patients to weigh the risks and benefits of drug administration and make informed decisions for drug use during pregnancy and lactation.
Life Sciences & Biomedicine Obstetrics & Gynecology Science & Technology

Details

Logo image